MRI coverage decision
This article was originally published in The Gray Sheet
CMS will allow local Medicare contractors to cover magnetic resonance imaging for measuring cardiac blood flow under a Sept. 28 1final decision. Until now, MRI for this purpose has been non-covered nationally. However, CMS is still forbidding coverage for MRI in patients who have a cardiac pacemaker. Medtronic, which is pursuing U.S. approval for its MRI-safe EnRhythm MRI SureScan pacemaker, had asked CMS to permit coverage for MRI procedures in patients with pacemakers or defibrillators that have been FDA-approved for use in an MRI environment (2"The Gray Sheet" July 6, 2009). CMS said Medtronic's request was "premature," since no MRI-safe pacemakers or ICDs have yet received FDA approval. Medtronic told "The Gray Sheet" that it expects to gain approval for EnRhythm and launch it in the U.S. by October 2010
You may also be interested in...
Use of magnetic resonance imaging to assess heart valve disease in Medicare patients may be an easier proposition for physicians if a June 30 CMS coverage 1proposal is adopted
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.